Gushudan
Gushudan has been studied in 2 papers since 2026: none in people yet, 2 in animals; 2 in the past year. The research so far is in animals. The newest paper, Jun 26, 2026: “A Dual‐Platform UHPLC‐MS Workflow for Bone Metabolomics Reveals BCAT2‐Associated Branched‐Chain Amino Acid Remodeling in Postmenopausal Osteoporosis”.
2 papers study it3 findingsUpdated
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals2
What did studies of gushudan find?
3Studies of gushudan measured 3 outcomes; the most studied are amino acid metabolism (1 study), PLA2G2A (1) and lipid-inflammatory crosstalk disorder (1).
Amino acid metabolism
upin rats1
1 study
Amino acid metabolism
upin rats1
Gushudan improves amino acid metabolism in ovariectomized rats.
“Quantitative analysis confirmed BCAA remodeling in osteoporotic bone and its partial normalization after GSD treatment.”
Animalsin ovariectomized ratsbone
Separation Science Plus
PLA2G2A
downin rats1
1 study
PLA2G2A
downin rats1
Gushudan decreases PLA2G2A in postmenopausal osteoporosis rats.
“suggesting that GSD might ameliorate the lipid-inflammatory crosstalk disorder in PMOP rats by downregulating Pla2g2a expression”
Animalsin postmenopausal osteoporosis rats
Analytical and bioanalytical chemistry
Lipid-inflammatory crosstalk disorder
downin rats1
1 study
Lipid-inflammatory crosstalk disorder
downin rats1
Gushudan decreases lipid-inflammatory crosstalk disorder in postmenopausal osteoporosis rats.
“GSD improved the disorder of the lipid-inflammatory crosstalk mechanism involving glycerophospholipids and arachidonic acid in PMOP rats”
Animalsin postmenopausal osteoporosis rats
Analytical and bioanalytical chemistry